Cisplatin

(Bio)chemical aspects of platinum-DNA interactions / Francisca Joanne Dijtschema:ProductModel Cellular resistance to adriamycin and cisplatin : the role of detoxifying systems / Jacoba Meyerschema:ProductModel Changing the balance in apoptosis : key to enhance cisplatin sensitivity of testicular cancer / Roelof Kosterschema:ProductModel Changing the balance in apoptosis : key to enhance cisplatin sensitivity of testicular cancer / Roelof Kosterschema:ProductModel Chemical-induced oxidative stress in the kidney : anti-oxidative strategies in cell models / Gerben Jacob Schaafschema:ProductModel Chemoprotection against cisplatin nephrotoxicity : a molecular approach with selenium compounds / Glenn Soerindre Baldewschema:ProductModel Chemotherapy-related cardiovascular morbidity in testicular cancer patients : markers & mechanisms / Renske Altenaschema:ProductModel Cis-Diamminedichloroplatinum (II) (Cisplatin) : clinical pharmacologic studies / Jan Baptist Vermorkenschema:ProductModel Cis-platinum and the kidney : renal function during treatment with cis-diammine-dichloro-platinum / Sijtze Meijerschema:ProductModel Cisplatin : health-based calculated occupational cancer risk values / Dutch Expert Committee on Occupational Standards, a committee of the Health Council of the Netherlandsschema:ProductModel Cisplatin and radiation induced hearing loss in head and neck cancer patients / Charlotte Louise Zuurschema:ProductModel Cisplatin and radiation induced hearing loss in head and neck cancer patients / Charlotte Louise Zuurschema:ProductModel Cisplatin induced distortions in DNA : structure and conformation of oligonucleotide-platinum adducts / Jeroen Hendrikus Joseph den Hartogschema:ProductModel Cisplatin nephrotoxicity: can it be prevented? / Joop Jacob Gerardus Offermanschema:ProductModel Cisplatin resistance: models, mechanisms, and modulation / Heintje Timmer-Bosschaschema:ProductModel Cisplatin scheduling and dosing aspects / Felix Ernst de Jonghschema:ProductModel Cisplatin scheduling and dosing aspects / Felix Ernst de Jonghschema:ProductModel Clinical and preclinical pharmacokinetic and dynamic studies with cisplatin, topotecan and docetaxel / Jianguo Maschema:ProductModel Clinical and preclinical pharmacokinetic and dynamic studies with cisplatin, topotecan and docetaxel / Jianguo Maschema:ProductModel Clinical pharmacology of anticancer agents in relation to formulations and administration routes / Jetske Muriel Meerum Terwogtschema:ProductModel ... show all 53